Cargando…
Metformin Inhibits Tumor Metastasis through Suppressing Hsp90α Secretion in an AMPKα1-PKCγ Dependent Manner
Metformin has been documented in epidemiological studies to mitigate tumor progression. Previous reports show that metformin inhibits tumor migration in several cell lines, such as MCF-7 and H1299, but the mechanisms whereby metformin exerts its inhibitory effects on tumor metastasis remain largely...
Autores principales: | Gong, Yuanchao, Wang, Caihong, Jiang, Yi, Zhang, Shaosen, Feng, Shi, Fu, Yan, Luo, Yongzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016760/ https://www.ncbi.nlm.nih.gov/pubmed/31936169 http://dx.doi.org/10.3390/cells9010144 |
Ejemplares similares
-
Extracellular Hsp90α Supports the ePKM2-GRP78-AKT Axis to Promote Tumor Metastasis
por: Zhang, Shaosen, et al.
Publicado: (2022) -
Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer
por: Hou, Qiaoyun, et al.
Publicado: (2021) -
Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer
por: Xue, Nina, et al.
Publicado: (2022) -
Targeting secreted heat shock protein-90alpha (Hsp90α) to prevent breast cancer progression
por: Zhao, Zhengwei, et al.
Publicado: (2010) -
The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)